- All sections
- C - Chemistry; metallurgy
- C12N - Microorganisms or enzymes; compositions thereof; propagating, preserving, or maintaining microorganisms; mutation or genetic engineering; culture media
- C12N 15/50 - Coronaviridae, e.g. infectious bronchitis virus, transmissible gastroenteritis virus
Patent holdings for IPC class C12N 15/50
Total number of patents in this class: 377
10-year publication summary
3
|
5
|
1
|
2
|
0
|
5
|
75
|
103
|
72
|
20
|
2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
Providence Therapeutics Holdings Inc. | 20 |
12 |
Guangzhou N Biomed Ltd. | 18 |
7 |
The Research Foundation for Microbial Diseases of Osaka University | 72 |
5 |
Cansino Biologics Inc. | 61 |
5 |
Institute of Microbiology, Chinese Academy of Sciences | 97 |
4 |
The James Hutton Institute | 28 |
4 |
Oncotherapy Science, Inc. | 302 |
4 |
Osaka University | 3143 |
4 |
Universite Laval | 703 |
4 |
The University of British Columbia | 1432 |
4 |
Fudan University | 585 |
3 |
Icahn School of Medicine at Mount Sinai | 859 |
3 |
Kanto Kagaku Kabushiki Kaisha | 88 |
3 |
Laboratorio Avi-Mex, S.A. de C.V. | 11 |
3 |
Medicago Inc. | 203 |
3 |
Public University Corporation Yokohama City University | 219 |
3 |
SunCor Energy Inc. | 838 |
3 |
Toyobo Co., Ltd. | 2286 |
3 |
The University of Tokyo | 3903 |
3 |
Jiangsu Provincial Center for Disease Control and Prevention (public Health Research Institute of Jiangsu Province) | 7 |
3 |
Other owners | 294 |